등록된 논문 168건

※ 클릭시 해당 논문페이지로 이동합니다.

• KCSG HN13-01두경부식도암

  Characteristics and treatment patterns in older patients with locally advanced head and neck cancer (KCSG HN13-01)

  • 저널 Korean J Intern Med . 2022 Jan;37(1):190-200.
  • 제1저자 강은주, 이윤규
  • 교신저자 윤환중

• NA위암

  Low PARP-1 expression level is an indicator of poor prognosis in patients with stage II and III gastric cancer

  • 저널 J Cancer. 2022 Jan 1;13(3):869-876.
  • 제1저자 박송이
  • 교신저자 황인규, 김희성

• KCSG ST19-16위암

  Ramucirumab plus paclitaxel as a second-line treatment in HER2-positive gastric cancer: subgroup analysis of a nationwide,real-world study in Korea (KCSG-ST19-16)

  • 저널 Gastric Cancer. 2022 May;25(3):609-618.
  • 제1저자 김범준, 지희정, 라선영
  • 교신저자 장대영

• KCSG ST19-16위암

  Ramucirumab plus paclitaxel as secondline treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16)

  • 저널 Ther Adv Med Oncol. 2021 Sep 18;13:17588359211042812.
  • 제1저자 한혜숙, 김범준, 지희정, 류민희
  • 교신저자 장대영

• KCSG LU19-05폐암

  Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05

  • 저널 J Cancer Res Clin Oncol. 2021 Aug;147(8):2459-2469.
  • 제1저자 박지현
  • 교신저자 강진형

• NANA

  Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group

  • 저널 Cancer Res Treat. 2022 Jan;54(1):1-9
  • 제1저자 윤신교
  • 교신저자 김지현

• NA간담췌암

  Efficacy and safety atezolizumab plus bevacizumab in Korean patients with advanced hepatocellular carcinoma

  • 저널 Liver Int. 2022 Mar;42(3):674-681.
  • 제1저자 천재경, 유창훈
  • 교신저자 전홍재, 임호영

• KCSG LU17-13폐암

  Characteristics and Outcome of ROS1-Positive Non-Small Cell Lung Cancer Patients in Routine Clinical Practice

  • 저널 J Thorac Oncol. 2018 Sep;13(9):1373-1382.
  • 제1저자 박세훈
  • 교신저자 안명주

• KCSG HN14-06두경부식도암

  A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

  • 저널 Cancer Medicine. 2021 Oct;10(20):7012-7020
  • 제1저자 이지현, 허성구
  • 교신저자 임선민, 김혜련

• KCSG LU13-05폐암

  An open-label expanded access program of afatinib in EGFR tyrosine kinase inhibitornaive patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR mutations

  • 저널 BMC Cancer. 2021 Jul 12;21(1):802.
  • 제1저자 박근칠
  • 교신저자 박근칠

678910